Nuveen
GOSS icon

Nuveen’s Gossamer Bio GOSS Stock Holding History

Nuveen’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85K Sell
17,324
-115,570
-87% -$32.3K ﹤0.01% 3734
2026
Q1 		$43.7K Sell
132,894
-175,628
-57% -$276K ﹤0.01% 3209
2025
Q4 		$956K Sell
308,522
-768,613
-71% -$2.19M ﹤0.01% 2635
2025
Q3 		$2.83M Buy
1,077,135
+830,271
+336% +$1.83M ﹤0.01% 2153
2025
Q2 		$304K Buy
+246,864
New +$269K ﹤0.01% 3051
2022
Q4 		– Sell
-513,793
Closed -$6.16M – 3218
2022
Q3 		$6.16M Buy
513,793
+350,167
+214% +$4.35M ﹤0.01% 1774
2022
Q2 		$1.37M Sell
163,626
-40,310
-20% -$312K ﹤0.01% 2635
2022
Q1 		$1.78M Sell
203,936
-3,018
-1% -$29.1K ﹤0.01% 2552
2021
Q4 		$2.13M Sell
206,954
-15,005
-7% -$178K ﹤0.01% 2544
2021
Q3 		$2.33M Sell
221,959
-6,388
-3% -$58.8K ﹤0.01% 2598
2021
Q2 		$1.85M Sell
228,347
-715,947
-76% -$6.21M ﹤0.01% 2753
2021
Q1 		$8.73M Buy
944,294
+226,078
+31% +$2.28M ﹤0.01% 1876
2020
Q4 		$6.95M Buy
718,216
+149,796
+26% +$1.48M ﹤0.01% 1908
2020
Q3 		$7.05M Buy
568,420
+380,130
+202% +$5.04M ﹤0.01% 1734
2020
Q2 		$2.45M Sell
188,290
-5,331
-3% -$67K ﹤0.01% 2250
2020
Q1 		$1.97M Buy
193,621
+15,381
+9% +$201K ﹤0.01% 2203
2019
Q4 		$2.79M Buy
178,240
+7,547
+4% +$152K ﹤0.01% 2283
2019
Q3 		$2.87M Buy
170,693
+73,624
+76% +$1.46M ﹤0.01% 2243
2019
Q2 		$2.15M Buy
+97,069
New +$1.86M ﹤0.01% 2400

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Nuveen's GOSS Position: Q2 2026 in Review

Nuveen reduced its Gossamer Bio (GOSS) stake by 87% in Q2 2026, selling an estimated $32.3K and leaving 17,324 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #3734.

Nuveen first reported a position in GOSS in Q2 2019 and has held it in 19 quarters since. The position peaked at $8.73M in Q1 2021. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Nuveen held 17,324 shares of Gossamer Bio worth $2.85K as of Q2 2026.
  • Nuveen sold 115,570 Gossamer Bio shares in Q2 2026, an estimated $32.3K.
  • Gossamer Bio made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3734 holding.
  • Nuveen first reported a position in Gossamer Bio in Q2 2019 and has held it in 19 quarters since.
  • Nuveen's Gossamer Bio position peaked at $8.73M in Q1 2021.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.